期刊的影响因子--文章列表

期刊文章列表
Minlin Jiang^1,2，Keyi Jia^1,2，Lei Wang¹，Wei Li¹，Bin Chen¹，Yu Liu^1,2，Hao Wang^1,2，Sha Zhao¹，Yayi He¹，Caicun Zhou¹（Department of Medical Oncology，Shanghai Pulmonary Hospital，Tongji University Medical School Cancer Institute，Tongji University School of Medicine；Medical School，Tongji University）.Alterations of DNA damage response pathway:Biomarker and therapeutic strategy for cancer immunotherapy[J].Acta Pharmaceutica Sinica B,2021,第10期 Qi Qiao¹，Xiong Liu¹，Ting Yang¹，Kexin Cui¹，Li Kong¹，Conglian Yang¹，Zhiping Zhang^1,2,3（Tongji School of Pharmacy，Huazhong University of Science and Technology；National Engineering Research Center for Nanomedicine，Huazhong University of Science and Technology；Hubei Engineering Research Center for Novel Drug Delivery System，Huazhong University of Science and Technology）.Nanomedicine for acute respiratory distress syndrome：The latest application, targeting strategy, and rational design[J].Acta Pharmaceutica Sinica B,2021,第10期 Lina Xu¹，Lianhong Yin¹，Yan Qi¹，Xuemei Tan¹，Meng Gao¹，Jinyong Peng^1,2,3（College of Pharmacy，Dalian Medical University；Key Laboratory for Basic and Applied Research on Pharmacodynamics Substances of Traditional Chinese Medicine of Liaoning Province，Dalian Medical University；National-Local Joint Engineering Research Center for Drug Development (R&D) of Neurodegenerative Diseases，Dalian Medical University）.3D disorganization and rearrangement of genome provide insights into pathogenesis of NAFLD by integrated Hi-C, Nanopore, and RNA sequencing[J].Acta Pharmaceutica Sinica B,2021,第10期 Yu Liang^1,2，Li Zhang¹，Chao Peng^1,2,3，Shiyu Zhang¹，Siwen Chen²，Xin Qian²，Wanxian Luo¹，Qing Dan¹，Yongyan Ren⁴，Yingjia Li¹，Bingxia Zhao²（Department of Medicine Ultrasonics，Nanfang Hospital，Southern Medical University；Guangzhou Key Laboratory of Tumor Immunology Research，Cancer Research Institute，School of Basic Medical Sciences，Southern Medical University；Department of Cerebrovascular Diseases，Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University)；Central Laboratory，Southern Medical University）.Tumor microenvironments self-activated nanoscale metal-organic frameworks for ferroptosis based cancer chemodynamic/photothermal/chemo therapy[J].Acta Pharmaceutica Sinica B,2021,第10期 Xiaoqing Du¹，Yuqi Hou¹，Jia Huang¹，Yan Pang¹，Chenlu Ruan¹，Wei Wu²，Chenjie Xu³，Hongwei Zhang⁴，Lifang Yin¹，Wei He¹（Department of Pharmaceutics，School of Pharmacy，China Pharmaceutical University；Key Laboratory of Smart Drug Delivery of Ministry of Education of China，School of Pharmacy，Fudan University；Department of Biomedical Engineering，City University of Hong Kong；Department of Pharmaceutical Sciences，School of Pharmacye Boston，MCPHS University）.Cytosolic delivery of the immunological adjuvant Poly Ⅰ:C and cytotoxic drug crystals via a carrier-free strategy significantly amplifies immune response[J].Acta Pharmaceutica Sinica B,2021,第10期 Xiaojia Liu¹，Mingxiao Yin¹，Jingwen Dong¹，Genxiang Mao²，Wenjian Min³，Zean Kuang¹，Peng Yang³，Lu Liu⁴，Na Zhang¹，Hongbin Deng¹（Institute of Medicinal Biotechnology，Chinese Academy of Medical Sciences & Peking Union Medical College；Zhejiang Provincial Key Lab of Geriatrics，Department of Geriatrics，Zhejiang Hospital；State Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of Drug Design and Optimization，China Pharmaceutical University；Qingdao Women and Children's Hospital，Qingdao University）.Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTOR[J].Acta Pharmaceutica Sinica B,2021,第10期 Yuli Wang^1,2,3，Xingyan Zhang^2,3,4，Yuyan Wang⁵，Wenjing Zhao⁶，Huling Li^2,3，Lixing Zhang¹，Xinping Li⁷，Tiejun Zhang^2,3，Hongbing Zhang^2,3，He Huang¹，Changxiao Liu^2,3（Key Laboratory of Systems Bioengineering (Ministry of Education)，School of Chemistry Engineering and Technology，Tianjin University；State Key Laboratory of Drug Delivery Technology and Pharmacokinetics，Tianjin Institute of Pharmaceutical Research；Tianjin Key Laboratory of Quality-Marker of Traditional Chinese Medicines，Tianjin Institute of Pharmaceutical Research；Tianjin University of Traditional Chinese Medicine；The Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)，Department of Thoracic Medical Oncology，Beijing Institute of Cancer Research；Department of Pharmacology，Tianjin Medical University；MITRO Biotech Co.，Ltd.）.Application of immune checkpoint targets in the anti-tumor novel drugs and traditional Chinese medicine development[J].Acta Pharmaceutica Sinica B,2021,第10期 Liuying Mao^1,2，Baolong Jin²，Lingli Chen²，Mei Tian²，Rui Ma²，Biwei Yin²，Haiyan Zhang²，Juan Guob¹，Jinfu Tang²，Tong Chen²，Changjiangsheng Lai²，Guanghong Cui²，Luqi Huang^1,2（College of Pharmacy，Shandong University of Chinese Medicine；State Key Laboratory of Dao-di Herbs，National Resource Center for Chinese Materia Medica，China Academy of Chinese Medical Sciences）.Functional identification of the terpene synthase family involved in diterpenoid alkaloids biosynthesis in Aconitum carmichaelii[J].Acta Pharmaceutica Sinica B,2021,第10期 Hao Ren¹，Jiahui Yong¹，Qingqing Yang¹，Zhen Yang¹，Zhangya Liu¹，Yan Xu¹，Hao Wang¹，Xing Jiang²，Wenjun Miao¹，Xueming Li¹（School of Pharmaceutical Science，Nanjing Tech University；School of Nursing，Nanjing University of Chinese Medicine）.Self-assembled FeS-based cascade bioreactor with enhanced tumor penetration and synergistic treatments to trigger robust cancer immunotherapy[J].Acta Pharmaceutica Sinica B,2021,第10期 Jianxiang Chen^1,2,3，Yiting Qiao^1,4，Guo Chen¹，Cunjie Chang²，Heng Dong²，Bo Tang⁵，Xiawei Cheng¹，Xiufeng Liu¹，Zichun Hua^1,5,6（School of Life Sciences，Nanjing University；College of Pharmacy，School of Medicine，Hangzhou Normal University；Department of Hepatology，the Affiliated Hospital of Hangzhou Normal University，Hangzhou Normal University；Division of Hepatobiliary and Pancreatic Surgery，Department of Surgery，the First Affiliated Hospital，School of Medicine，Zhejiang University；Changzhou High-Tech Research Institute of Nanjing University and Jiangsu Target Pharma Laboratories Inc.；School of Biopharmacy，China Pharmaceutical University）.Salmonella flagella confer anti-tumor immunological effect via activating Flagellin/TLR5 signalling within tumor microenvironment[J].Acta Pharmaceutica Sinica B,2021,第10期 Tingting Peng¹，Yao Huang²，Xiaoqian Feng²，Chune Zhu³，Shi Yin²，Xinyi Wang⁴，Xuequn Bai²，Xin Pan²，Chuanbin Wu^1,2（College of Pharmacy，Jinan University；School of Pharmaceutical Sciences，Sun Yat-sen University；School of Traditional Chinese Medicine，Guangdong Pharmaceutical University；Guanghua School of Stomatology，Hospital of Stomatology，Sun Yat-sen University）.TPGS/hyaluronic acid dual-functionalized PLGA nanoparticles delivered through dissolving microneedles for markedly improved chemo-photothermal combined therapy of superficial tumor[J].Acta Pharmaceutica Sinica B,2021,第10期 Kai Zhang¹，Shiou Zhu¹，Jiamei Li¹，Tingting Jiang¹，Lu Feng¹，Junping Pei¹，Guan Wang^1,2，Liang Ouyang¹，Bo Liu¹（State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，Collaborative Innovation Center of Biotherapy，Sichuan University；Innovation Center of Nursing Research，Nursing Key Laboratory of Sichuan Province，West China Hospital，Sichuan University）.Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson’s disease[J].Acta Pharmaceutica Sinica B,2021,第10期 Jian Lu^1,2，Jie Liu^1,2，Yuanqing Guo¹，Yuanjin Zhang¹，Yeye Xu¹，Xin Wang^1,2（Changning Maternity and Infant Health Hospital，East China Normal University；Shanghai Key Laboratory of Regulatory Biology，Institute of Biomedical Sciences and School of Life Sciences，East China Normal University）.CRISPR-Cas9：A method for establishing rat models of drug metabolism and pharmacokinetics[J].Acta Pharmaceutica Sinica B,2021,第10期 Xiu Han^1,2，Xiang Xu¹，Ziheng Wu³，Zhenghong Wu¹，Xiaole Qi¹（Key Laboratory of Modern Chinese Medicines，China Pharmaceutical University；Medical School of Nanjing University，Nanjing University；Parkville Campus，Monash University）.Synchronous conjugation of i-motif DNA and therapeutic siRNA on the vertexes of tetrahedral DNA nanocages for efficient gene silence[J].Acta Pharmaceutica Sinica B,2021,第10期 Liting Cheng¹，Miao-Miao Niu²，Tong Yana¹，Zhongyi Ma¹，Kexin Huang¹，Ling Yang¹，Xin Zhong¹，Chong Li¹（Medical Research Institute，College of Pharmaceutical Sciences，Southwest University；Key Laboratory of Drug Quality Control and Pharmacovigilance (Ministry of Education)，China Pharmaceutical University）.Bioresponsive micro-to-nano albumin-based systems for targeted drug delivery against complex fungal infections[J].Acta Pharmaceutica Sinica B,2021,第10期 Dan Li¹，Yingli Wang¹，Chang Li¹，Qiu Wang¹，Bingjun Sun¹，Haotian Zhang²，Zhonggui He¹，Jin Sun¹（Department of Pharmaceutics，Wuya College of Innovation，Shenyang Pharmaceutical University；School of Life Science and Biopharmaceutics，Shenyang Pharmaceutical University）.Cancer-specific calcium nanoregulator suppressing the generation and circulation of circulating tumor cell clusters for enhanced anti-metastasis combinational chemotherapy[J].Acta Pharmaceutica Sinica B,2021,第10期 Hao Wang，Bo-Yong Zhang，Ting Gong，Tian-Jiao Chen，Jing-Jing Chen，Jin-Ling Yang，Ping Zhu（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，NHC Key Laboratory of Biosynthesis of Natural Products，CAMS Key Laboratory of Enzyme and Biocatalysis of Natural Drugs，Institute of Materia Medica，Chinese Academy of Medical Sciences & Peking Union Medical College）.Construction of acetyl-CoA and DBAT hybrid metabolic pathway for acetylation of 10-deacetylbaccatin Ⅲ to baccatin Ⅲ[J].Acta Pharmaceutica Sinica B,2021,第10期 Min Luo¹，Yuhui Xia¹，Fang Wang¹，Hong Zhang¹，Danting Su¹，Chaoyue Su^1,2，Chuan Yang¹，Shaocong Wu¹，Sainan An¹，Suxia Lin¹，Liwu Fu¹（State Key Laboratory of Oncology in South China，Collaborative Innovation Center for Cancer Medicine，Guangdong Esophageal Cancer Institute，Sun Yat-sen University Cancer Center；Pharmacy College，Guangzhou Medical University）.PD0325901, an ERK inhibitor, enhances the efficacy of PD-1 inhibitor in non-small cell lung carcinoma[J].Acta Pharmaceutica Sinica B,2021,第10期 Jing Zhu^1,2，Meng Xin^1,3，Congcong Xu¹，Yuan He⁴，Wannian Zhang^1,2，Zhibin Wang¹，Chunlin Zhuang^1,2（School of Pharmacy，Second Military Medical University；School of Pharmacy，Ningxia Medical University；Department of Pharmacy，Shanghai Municipal Hospital of Traditional Chinese Medicine；Tongji University Cancer Center，Shanghai Tenth People's Hospital，School of Medicine，Tongji University）.Ligand-based substituent-anchoring design of selective receptor-interacting protein kinase 1 necroptosis inhibitors for ulcerative colitis therapy[J].Acta Pharmaceutica Sinica B,2021,第10期 Shanshan Liu¹，Xiaoxi Lv¹，Xupeng Wei²，Chang Liu¹，Qiao Li³，Jiali Min³，Fang Hua¹，Xiaowei Zhang¹，Ke Li⁴，Pingping Li¹，Yang Xiao³，Zhuowei Hu¹，Bing Cui¹（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，CAMS Key Laboratory of Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis，Chinese Academy of Medical Sciences & Peking Union Medical College；Department of Pharmacy，Pharmacy College，Hebei University；National Clinical Research Center for Metabolic Diseases，Department of Metabolism and Endocrinology，the Second Xiangya Hospital，Central South University；Institute of Medicinal Biotechnology，Chinese Academy of Medical Sciences & Peking Union Medical College）.TRIB3-GSK-3β interaction promotes lung fibrosis and serves as a potential therapeutic target[J].Acta Pharmaceutica Sinica B,2021,第10期 Tian Lu^1,2，Yong Li^3,2,4，Wenchao Lu⁵，TWGM Spitters⁶，Xueyu Fang⁶，Jun Wang⁷，Simian Cai⁶，Jing Gao⁸，Yanting Zhou⁸，Zhe Duan^3,9，Huan Xiong¹⁰，Liping Liu³，Qi Li³，Hualiang Jiang³，Kaixian Chen^1,3,6，Hu Zhou⁸，Hua Lin³，Huijin Feng²，Bing Zhou^2,4，Christopher L.Antos⁶，Cheng Luo^1,2,6,4（School of Chinese Materia Medica，Nanjing University of Chinese Medicine；Department of Medicinal Chemistry，State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；The Center for Chemical Biology，Drug Discovery and Design Center，State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；School of Pharmaceutical Science and Technology，Hangzhou Institute for Advanced Study，University of Chinese Academy of Sciences；Department of Cancer Biology，Dana-Farber Cancer Institute；School of Life Science and Technology，Shanghai Tech University；School of Life Sciences and Biotechnology，Shanghai Jiao Tong University；Department of Analytical Chemistry and CAS Key Laboratory of Receptor Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；School of Pharmacy，Nanchang University；Pharmacological and Toxicological Chemistry and Biochemistry Laboratory，UMR 8601 CNRS，University of Paris）.Discovery of a subtype-selective, covalent inhibitor against palmitoylation pocket of TEAD3[J].Acta Pharmaceutica Sinica B,2021,第10期 Shu Song¹，Ping Gao¹，Lin Sun¹，Dongwei Kang¹，Jacob Kongsted²，Vasanthanathan Poongavanam²，Peng Zhan¹，Xinyong Liu¹（Department of Medicinal Chemistry，Key Laboratory of Chemical Biology，Ministry of Education，School of Pharmaceutical Sciences，Shandong University；Department of Physics，Chemistry and Pharmacy，University of Southern Denmark）.Recent developments in the medicinal chemistry of single boron atom-containing compounds[J].Acta Pharmaceutica Sinica B,2021,第10期 Po Hu¹，Hui Li¹，Wenzhuo Sun¹，Hongzheng Wang¹，Xiaoxuan Yu^1,2，Yingjie Qing¹，Zhanyu Wang¹，Mengyuan Zhu¹，Jingyan Xu³，Qinglong Guo¹，Hui Hui¹（State Key Laboratory of Natural Medicines，Jiangsu Key Laboratory of Carcinogenesis and Intervention，China Pharmaceutical University；Department of Pharmacology，School of Medicine & Holostic Integrative Medicine，Nanjing University of Chinese Medicine；Department of Hematology，the Affiliated Drum Tower Hospital of Nanjing University Medical School）.Cholesterol-associated lysosomal disorder triggers cell death of hematological malignancy:Dynamic analysis on cytotoxic effects of LW-218[J].Acta Pharmaceutica Sinica B,2021,第10期 Le Zhang^1,2,3，Lei Zhang¹，Yue Guo¹，Ming Xiao¹，Lu Feng¹，Chengcan Yang¹，Guan Wang^1,2，Liang Ouyang¹（Innovation Center of Nursing Research，West China Biomedical Big Data Center，State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，College of Computer Science，and Collaborative Innovation Center of Biotherapy，Sichuan University；Nursing Key Laboratory of Sichuan Province，West China Hospital，Sichuan University；Pera Corporation Ltd.）.MCDB：A comprehensive curated mitotic catastrophe database for retrieval, protein sequence alignment, and target prediction[J].Acta Pharmaceutica Sinica B,2021,第10期 Bin Lu^1,2，Jianpin Ye³（The Second Affiliated Hospital，Hengyang Medical School，University of South China；Protein Quality Control and Diseases Laboratory，School of Laboratory Medicine and Life Sciences，Wenzhou Medical University；Zhengzhou Central Hospital Affiliated to Zhengzhou University）.Commentary：PROTACs make undruggable targets druggable：Challenge and opportunity[J].Acta Pharmaceutica Sinica B,2021,第10期 Arun Upadhyay（Department of Biochemistry，Central University of Rajasthan）.Natural compounds in the regulation of proteostatic pathways：An invincible artillery against stress, ageing, and diseases[J].Acta Pharmaceutica Sinica B,2021,第10期 Editoral Office of Acta Pharmaceutica Sinica（Editoral Office of Acta Pharmaceutica Sinica）.Information for Authors[J].Acta Pharmaceutica Sinica B,2021,第10期 Brandon E.Burdette¹，Ashley N.Esparza¹，Hua Zhu²，Shanzhi Wang¹（Biology Department,University of Arkansas at Little Rock；Department of Surgery,the Ohio State University Wexner Medical Center）.Gasdermin D in pyroptosis[J].Acta Pharmaceutica Sinica B,2021,第9期首页上一页 1 2 3 4 5 下一页尾页共有11页，转到页

期刊文章列表